Articles tagged with Cell Death
A recent clinical study found that ONC201 caused cell death in various tumor types, even when the p53 protein was mutated or deleted. The drug has shown promise in treating hematological malignancies, including leukemia and lymphoma patients, with clinical trials recently initiated.
A study found that aspirin's breakdown product salicylic acid blocks cell death associated with Alzheimer's, Parkinson's and Huntington's disease by inhibiting the GAPDH enzyme. Derivatives of salicylic acid may hold promise for treating multiple neurodegenerative diseases.
Researchers at York University have discovered that beta-blockers may prevent further cell death following a heart attack, potentially leading to better long-term patient outcomes. The study found that the protein complex MEF2 plays a key role in heart cell survival and gene expression.
Researchers have discovered the molecular culprits behind primary open-angle glaucoma, a leading cause of blindness, by identifying two key risk genes: SIX6 and P16. The study found that high eye pressure increases expression of P16, linking it to increased risk of vision loss.
Scientists have identified a gatekeeper enzyme that prevents cell death in Wolfram syndrome, a rare form of diabetes. Replacing or enhancing the enzyme strengthens cellular membranes and stops molecules from leaking into other parts of the cell.
Researchers identified a cellular mechanism that can be targeted to treat ALS by increasing levels of protein hUPF1, which successfully protected against cell death in both genetic and sporadic versions of the disease. Treating this pathway may also have implications for frontotemporal dementia.
A recent study found that saturated fatty acids can induce cell death in cardiac muscle cells through endoplasmic reticulum stress. In contrast, unsaturated fatty acids protect these cells from damage. The research suggests a critical role for saturated fatty acids in heart disease development.
A new method for minimally invasive tissue ablation surgery combines electrolysis with reversible electroporation, increasing the effectiveness of the procedure. The technique allows for faster treatment and greater control over the target area, potentially leading to safer and more effective cancer treatment.
A new chemical compound, KIRA6, has shown significant protection against degenerative forms of blindness and diabetes in rats and mice. The research offers a promising drug-development path for the diseases caused by cell loss and provides insights into the unfolded protein response (UPR) network.
Researchers have unraveled the mechanism of necroptosis, a type of cell death linked to various diseases. Understanding this process enables the development of targeted medications to block or stimulate necroptosis, potentially treating chronic and acute inflammatory and degenerative diseases.
Blocking extrasynaptic NMDA receptors may improve motor learning, coordination and prevent cell death in animal models of Huntington disease. This finding could lead to new treatment avenues for neurodegenerative conditions such as Alzheimer's disease and traumatic brain injury.
Researchers developed a new, high-tech device for transferring DNA into cells with minimal stress, reducing cell death rates. The MEMS nanoinjector uses electrical forces to inject DNA into cells without using extra fluid.
Researchers identify CLP1 as a cause of a rare neurological disorder affecting brain development and peripheral nerves, leading to cell death in neural progenitor cells. The study reveals a new mechanism involving tRNA biogenesis, which explains the disorder's symptoms.
Researchers at Scripps Research Institute develop new drug discovery technique to quickly and cheaply identify antibodies that protect human cells from viral infections. The technique successfully identifies two antibodies that prevent cold virus-induced cell death, highlighting its potential for treating various diseases.
Researchers at Duke University Medical Center found a high presence of bacteria at the site where fetal membranes rupture may be associated with premature water breaking. The study suggests that bacterial presence is linked to thinning of the fetal membranes, which can lead to preterm births.
A newly developed mouse trauma model reveals that the brain's protective coverings feel the brunt of even mild traumatic brain injuries. Researchers discovered a similar immune response in patients with mild head injury, suggesting a new potential treatment approach.
Researchers discover that prion protein has a 'switch' controlling its toxicity, which can be triggered by antibodies targeting the flexible tail. The study finds that only antibodies targeting the tail are suitable for use as potential drugs, while those triggering the switch are harmful.
Kuo-Fen Lee's discovery of the protein P45 provides insight into a possible molecular mechanism to promote rerouting for spinal cord healing and functional recovery. P45 has been shown to have a previously unknown neuroprotective effect, preventing cell death in injured mice.
A recent study challenged the long-held understanding of how antibiotics work, finding that all antibiotics induce bacterial cells to make compounds called reactive oxygen species, making bacteria susceptible. The results contradict previous findings and suggest a need to re-evaluate the mechanisms of antibiotic action.
University of Iowa researchers have discovered that CaM kinase II triggers cell death in heart cells following a heart attack. Blocking the enzyme can prevent heart cells from dying and protect against heart failure.
Researchers at Wake Forest Baptist Medical Center have developed a new device called mechanical tissue resuscitation (MTR) that uses negative pressure to reduce cell death and improve brain function after traumatic brain injury. The technology showed significant promise in reducing brain swelling and preserving more than 50% of damaged...
Researchers found that a key signaling pathway, Wnt, plays an important role in the disease and may offer a potential treatment target. The study suggests increasing a specific receptor, FZD2, could promote brain-cell survival and alleviate symptoms.
Scientists at WashU Medicine identified three unexpected players, small RNA molecules, that help a cell initiated its own demise when overloaded with fat. The research links these molecules to the cellular damage characteristic of common metabolic diseases like diabetes.
Researchers at Rutgers University have identified P75 as a likely culprit in post-seizure brain cell death, which can benefit people with epilepsy and those suffering from traumatic brain injuries and strokes. The study aims to prevent cell death by testing molecules that block the P75 receptor.
Researchers have uncovered how yeast cells recognize and assemble cargo mRNA for transport, a process critical for cell function. The discovery sheds new light on the mechanisms underlying molecular transport in both simple and complex organisms.
Researchers found that the process of repairing damaged DNA repeats can lead to cell death in yeast, providing insight into neurodegenerative diseases. The study suggests that expanded DNA repeats can be toxic to cells, contributing to disease progression.
Researchers at UC Riverside have identified a chemical compound, blebbistatin, that inhibits the molecular motor NMII and prevents cell death in human pluripotent stem cells. This breakthrough discovery brings stem cell research closer to finding therapies for various diseases.
Scientists at the Brain Research Centre have discovered a new mechanism for brain cell death after a stroke, involving the over-activation of NMDA receptors and a protein called SREBP-1. A potential therapy has been found, using a drug that stabilizes Insig-1 to inhibit SREBP-1 activity.
A Purdue University researcher has discovered that increasing protein phosphatase 5 (PP5) in neurons reduces reactive oxygen species-induced cell death, a mechanism linked to Alzheimer's disease. PP5 overexpression also prevents amyloid beta-mediated stress pathways.
University of Cincinnati researchers have identified a specific step in the biological chain of events leading to Diamond Blackfan anemia. They discovered that a ribosomal protein defect leads to abnormal activation of p53, causing premature death of red blood cells.
Researchers found that blocking Cyclophilin D and developing surrounding mitochondrial targets may be viable strategies for preventing and treating Alzheimer's disease. The study provides new insights into the mechanism underlying amyloid beta-mediated mitochondrial stress, which links to synaptic plasticity and learning/memory.
Researchers at the University of Montreal have discovered a potential new treatment for cardiac complications in Duchenne muscular dystrophy patients. The study, published in the Proceedings of the National Academy of Sciences, shows that administering sildenafil protects the heart in mice with the disease.
A study by University of Iowa researchers reveals a new dimension for a key heart enzyme and sheds light on an important biological pathway involved in cell death in heart disease. The team found that oxidation can sustain the enzyme's activity, which is implicated in arrhythmias, hypertrophy, and heart cell death.
Researchers at Ohio State University Medical Center found that the mitochondria send a death signal to cardiac cells when blood flow is restored, leading to cell damage and weakening heart function. The study identifies a specific enzyme, mitochondrial nitric oxide synthase, as a potential therapeutic target to stop this process.
Researchers found that inactivating TNFa significantly reduced blood vessel impairment and cell death in aged vessels, suggesting a link between increased TNFa levels and cardiovascular disease. The study's findings could lead to the development of new treatments for age-related vascular diseases.
Researchers found transcription factor Elk-1 localized in dendrites of neurons, affecting cell viability. Overexpressing Elk-1 decreased cell viability, while knocking down expression increased neuron survival.
Researchers found that cytotoxic T lymphocytes (CTLs) kill only a fraction of infected cells, with most deaths attributed to other factors. The study suggests that CTL-based vaccines may not prevent or clear HIV infection and could control the number of infected cells instead.
Researchers at Washington University School of Medicine in St. Louis have identified EF1A-1 as a critical step in the pathway leading to high cellular fat and cell death. The protein plays a role in protein synthesis and cytoskeleton maintenance, and its presence dictates sensitivity to palmitate-induced cell death.
Researchers found that over half of the 46 known microRNAs are essential for development, affecting it in specific ways. MicroRNAs regulate fundamental processes such as body patterning, morphogenesis, and nervous system development.
Researchers have made significant breakthroughs in understanding a natural mechanism cells use to protect themselves from stress, with potential applications for preventing motor nerve cell death. Up to 50% of nerve cell death could be prevented in mice with sciatic nerve injury using this approach.
A recent study published in Molecular Psychiatry reveals that cell death promotes learning and growth in the brain. The research found that rats with lower levels of cell death performed better in spatial learning tasks, suggesting a positive correlation between cell death and cognitive function.
Researchers found that cardiac MRI technology can detect small areas of heart muscle death that are missed by traditional nuclear imaging techniques like SPECT. This is important because these microinfarcts can be early indicators of future severe heart problems.
Researchers have discovered a new way to prevent cell death in the brain, which could lead to treatments for stroke, schizophrenia, and other neurological disorders. By enhancing the interaction between two proteins, they may be able to design medications that target specific brain functions.
Researchers discovered how E. coli O157:H7 causes massive cell death in humans, leading to organ failure and death. The bacteria's verotoxins trigger programmed cell death through a Bcl-2 protein sequence, offering potential new treatments for food poisoning.
Researchers at University of Toronto have identified a common principle underlying brain cell death in neurodegenerative disorders. They propose a 'one-hit' model, where cells die after a single catastrophic event, rather than gradual damage over time.